Evidence map›Paper›PMID 41127318›Full record

ArticleFrontiers in genetics2025

Correction: FEZF1-AS1 drives autophagy-mediated progression of colon cancer and reduces chemosensitivity through inhabiting the PI3K/AKT/mTOR signaling pathway.

Xiaoping Yang, Zuohui Yuan, Lingzhu Gou, Long Cheng, Zirui Wang, Pingfan Wu, Xiaochun Wang, Xueni Ma, Tiantian Ma, Yi Yu and 2 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Xiaoping YangKey Laboratory of Digestive Diseases of Gansu Province, The Second Hospital and Clinical Medical School, Lanzhou University, Lanzhou, China.
Zuohui YuanDepartment of Gastroenterology, Gansu Provincial Hospital, Lanzhou, China.
Lingzhu GouKey Laboratory of Digestive Diseases of Gansu Province, The Second Hospital and Clinical Medical School, Lanzhou University, Lanzhou, China.
Long ChengKey Laboratory of Digestive Diseases of Gansu Province, The Second Hospital and Clinical Medical School, Lanzhou University, Lanzhou, China.
Zirui WangDepartment of Urology, The Second People's Hospital of Lanzhou, Lanzhou, China.
Pingfan WuDepartment of Pathology, The Sixth Affiliated Hospital, School of Medicine, South China University of Technology, Foshan, China.
Xiaochun WangDepartment of Gastroenterology, Gansu Provincial Hospital, Lanzhou, China.
Xueni MaKey Laboratory of Digestive Diseases of Gansu Province, The Second Hospital and Clinical Medical School, Lanzhou University, Lanzhou, China.
Tiantian MaDepartment of Pneumology, Xi An Chest Hospital, Xian, China.
Yi YuDepartment of Gastroenterology, The Second Hospital and Clinical Medical School, Lanzhou University, Lanzhou, China.
Zhiping WuDepartment of Gastroenterology, The Second Hospital and Clinical Medical School, Lanzhou University, Lanzhou, China.
Dekui ZhangKey Laboratory of Digestive Diseases of Gansu Province, The Second Hospital and Clinical Medical School, Lanzhou University, Lanzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fgene.2025.1514205.].

Indexed as

autophagychemosensitivitycolon cancerFEZF1-AS1PI3K/AKT/mTOR

Identifiers

PMID41127318
PMCPMC12538511

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.